Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab

被引：0
|
作者：
Elliott, Elizabeth [1 ]
Waheed, Salman [2 ]
Syed, Sahr [3 ]
Eswaran, Sheila [4 ]
Gregory, Stephanie [5 ]
Shammo, Jamile [5 ]
机构：
[1] Rush Univ, Med Ctr, Dept Internal Med, 1653 W Congress Pkway, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Div Hematol & Oncol, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Sect Hepatol, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Sect Hematol, Chicago, IL 60612 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷 / 01期
关键词：
Anticomplement C5 therapy; Hemoglobinuria; Hemolysis; Iron metabolism; Iron overload; APLASTIC-ANEMIA; DIAGNOSIS; GUIDELINES; MANAGEMENT; IRON;
D O I：
10.1016/j.clml.2017.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E9 / E12
页数：4
相关论文
共 50 条
  • [41] Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab
    Krishnan, Suresh K.
    Hill, Anita
    Hillmen, Peter
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Wood, Alex
    Scarsbrook, Andrew
    Davies, Mervyn H.
    Kelly, Richard J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 716 - 718
  • [42] Paroxysmal nocturnal hemoglobinuria
    Mahmood, Asad
    Sharif, Muhammad Ashraf
    Murtaza, Badar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (08): : 512 - 514
  • [43] PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: FROM PHYSIOPATHOLOGY TO TREATMENT
    de Almeida Santos Arruda, Martha Mariana
    Rodrigues, Celso Arrais
    Yamamoto, Mihoko
    Figueiredo, Maria Stella
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2010, 56 (02): : 214 - 221
  • [44] Emerging drugs for the treatment of paroxysmal nocturnal hemoglobinuria
    Frieri, Camilla
    de Latour, Regis Peffault
    De Fontbrune, Flore Sicre
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (01) : 33 - 43
  • [45] Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria
    Yoo, Justin J.
    Chonat, Satheesh
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (05) : 385 - 392
  • [46] PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA IN INDIANS
    KODURI, PR
    GOWRISHANKAR, S
    ACTA HAEMATOLOGICA, 1992, 88 (2-3) : 126 - 128
  • [47] Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Elebute, Modupe
    Kelly, Richard
    Urbano-Ispizua, Alvaro
    Hill, Anita
    Rother, Russell P.
    Khursigara, Gus
    Fu, Chieh-Lin
    Omine, Mitsuhiro
    Browne, Paul
    Rosse, Wendell
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) : 553 - 559
  • [48] Increased eculizumab requirements during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report and review of the literature
    Patriquin, Christopher
    Leber, Brian
    CLINICAL CASE REPORTS, 2015, 3 (02): : 88 - 91
  • [49] Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Weitz, Ilene C.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (03) : 315 - 321
  • [50] Laboratory tests for paroxysmal nocturnal hemoglobinuria
    Preis, Meir
    Lowrey, Christopher H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) : 339 - 341
12345